Publications of Anthony D. So    :chronological  alphabetical  combined  bibtex listing:

We've launched a new site so please go to People & Research for current information on our faculty and staff.

Journal Articles

  1. Jørgensen, PS; Wernli, D; Carroll, SP; Dunn, RR; Harbarth, S; Levin, SA; So, AD; Schlüter, M; Laxminarayan, R. "Use antimicrobials wisely.." Nature 537.7619 (September, 2016): 159-161. [doi]
  2. Outterson, K; Gopinathan, U; Clift, C; So, AD; Morel, CM; Røttingen, J-A. "Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.." PLoS medicine 13.6 (June, 2016): e1002043. [doi]  [abs]
  3. Dar, OA; Hasan, R; Schlundt, J; Harbarth, S; Caleo, G; Dar, FK; Littmann, J; Rweyemamu, M; Buckley, EJ; Shahid, M; Kock, R; Li, HL; Giha, H; Khan, M; So, AD; Bindayna, KM; Kessel, A; Pedersen, HB; Permanand, G; Zumla, A; Røttingen, J-A; Heymann, DL. "Exploring the evidence base for national and regional policy interventions to combat resistance.." The Lancet 387.10015 (January, 2016): 285-295. [doi]  [abs]
  4. So, AD; Shah, TA; Roach, S; Ling Chee, Y; Nachman, KE. "An Integrated Systems Approach is Needed to Ensure the Sustainability of Antibiotic Effectiveness for Both Humans and Animals.." The Journal of Law, Medicine & Ethics 43 Suppl 3.S3 (January, 2015): 38-45. [doi]  [abs]
  5. Ahsan, A; Wiyono, NH; Setyonaluri, D; Denniston, R; So, AD. "Illicit cigarette consumption and government revenue loss in Indonesia.." Globalization and Health 10 (November, 2014): 75. [doi]  [abs]
  6. So, AD; Shah, TA. "New business models for antibiotic innovation.." Upsala Journal of Medical Sciences 119.2 (May, 2014): 176-180. [repository], [doi]  [abs]
  7. Nguyen, MT; Denniston, R; Nguyen, HTT; Hoang, TA; Ross, H; So, AD. "The empirical analysis of cigarette tax avoidance and illicit trade in Vietnam, 1998-2010.." PloS one 9.1 (January, 2014): e87272. [repository], [doi]  [abs]
  8. Laxminarayan, R; Duse, A; Wattal, C; Zaidi, AKM; Wertheim, HFL; Sumpradit, N; Vlieghe, E; Hara, GL; Gould, IM; Goossens, H; Greko, C; So, AD; Bigdeli, M; Tomson, G; Woodhouse, W; Ombaka, E; Peralta, AQ; Qamar, FN; Mir, F; Kariuki, S; Bhutta, ZA; Coates, A; Bergstrom, R; Wright, GD; Brown, ED; Cars, O. "Antibiotic resistance—the need for global solutions." The Lancet Infectious Diseases 13.12 (December, 2013): 1057-1098. [abstract], [doi]
  9. So AD, Bigeli M, Tomson G, Woodhouse W, Ombaka E, Quizhpe Peralta A. "The access and excess dilemma." The Lancet Infectious Diseases (November, 2013). (Part 5 of "Antibiotic resistance - the need for global solutions" by Cars O, et al.) [pdf]  [abs]
  10. So A, Ruiz-Esparza Q, Gupta N, Cars O. "3Rs for Innovating Conserving Novel Antibiotics: Sharing Resources, Risks and Rewards." British Medical Journal (April, 2012). [bmj.e1782]
  11. So A. "Challenges in Sharing Knowledge for Global Health." World Politics Review (March, 2012). [pdf]
  12. So, AD; Chang, S. "Fostering Innovation to Combat Antimicrobial Resistance." The Evolving Threat of Antimicrobial Resistance: Options for action (March, 2012): 77-90. [pdf]  [abs] [author's comments]
  13. So, AD. "IPR and Global Health: The Challenge of Knowledge-Sharing." World Politics Review (February, 2012): 14-19. [pdf]
  14. So, A; Sachs, R. "Making Intellectual Property Work for Global Health." Harvard International Law Journal 53 (February, 2012): 106-143. [available here]  [abs]
  15. with So, AD; Ruiz-Esparza, Q. "Technology innovation for infectious diseases in the developing world." Infectious Diseases of Poverty 1.1 (2012): 2-2. [2], [doi]
  16. So, AD; Ruiz-Esparza, Q; Gupta, N; Cars, O. "3Rs for innovating novel antibiotics: Sharing resources, risks, and rewards." BMJ 344.7852 (2012). [repository], [doi]
  17. So, AD; Furlong, M; Meredith, S; Bochorishvili, I; Diap, G. "Implementation Research for the Control of Infectious Diseases of Poverty: Strengthening the evidence base for access and delivery of new and improved tools, strategies and interventions." (October, 2011): 67-80. [pdf]  [abs]
  18. So, A; Oh, C. "Approaches to Intellectual Property and Innovation That Meet the Public Health Challenge of AIDS.." (July, 2011): 1-22. [working-papers]  [abs] [author's comments]
  19. A. So, Furlong M, Meredith S, Bochorishvili I, Diap G. "Implementation Research and Product Development Partnerships." Implementation Research for the Control of Infectious Diseases of Poverty: Strengthening the evidence base for access and delivery of new and improved tools, strategies and interventions. (2011). [pdf]
  20. Freire-Moran, L; Aronsson, B; Manz, C; Gyssens, IC; So, AD; Monnet, DL; Cars, O. "Critical shortage of new antibiotics in development against multidrug-resistant bacteria - Time to react is now." Drug Resistance Updates 14.2 (2011): 118-124. [S1368764611000197], [doi]  [abs]
  21. So, AD; Gupta, N; Brahmachari, SK; Chopra, I; Munos, B; Nathan, C; Outterson, K; Paccaud, JP; Payne, DJ; Peeling, RW; Spigelman, M; Weigelt, J. "Towards new business models for R&D for novel antibiotics." Drug Resistance Updates 14.2 (2011): 88-94. [S1368764611000161], [doi]  [abs]
  22. So, A; Furlong, M; Heddini, A. "Globalisation and antibiotic resistance.." BMJ (Clinical research ed.) 341.7774 (2010): c5116. [repository], [doi]
  23. So, AD; Gupta, N; Cars, O. "Tackling antibiotic resistance.." BMJ (Clinical research ed.) 340.7756 (2010): c2071. [repository], [doi]
  24. So, A. "Between pull and pools, where’s the ‘push’ for global health R&D?." Innovating for the Health of All 6 (December, 2009): 119-122. [pdf]
  25. So, A; Stewart, E. "Sharing Knowledge for Global Health.." (2009). [available here]
  26. Reichman, J; So, A; Sampat, B; Cook-Deegan, R; Weissman, R; Kapczynski, A. "Is Bayh-Dole Good for Developing Countries? Lessons from the U.S. Experience." PLoS Biology 6.10 (2008): 2078-2084. [18959484], [doi]
  27. Cars, O; Högberg, LD; Murray, M; Nordberg, O; Sivaraman, S; Lundborg, CS; So, AD; Tomson, G. "Meeting the challenge of antibiotic resistance." British Medical Journal 337.7672 (2008): 726-728.
  28. Lewis, TR; Reichman, JH; So, AD. "The case for public funding and public oversight of clinical trials." Economists' Voice 4.1 (2007): 1-4.
  29. So, AD. "A fair deal for the future: Flexibilities under TRIPS." Bulletin of the World Health Organization 82.11 (2004): 813-813. [available here]

Op-eds

  1. So AD, Katz SL. Biologics Boondoggle.  The New York Times (March 7, 2010). [08so.html]

Anthony D. So